Holocene Advisors Portfolio holdings
AUM
$40.6B
1-Year Return
31.17%
This Quarter Return
+16.12%
1 Year Return
+31.17%
3 Year Return
+129.55%
5 Year Return
+263.78%
10 Year Return
–
AUM
$25.5B
AUM Growth
+$3.13B
(+14%)
Cap. Flow
+$553M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
15.43%
Holding
864
New
167
Increased
213
Reduced
287
Closed
185
Top Buys
| 1 |
Amazon
AMZN
|
$354M |
| 2 |
AbbVie
ABBV
|
$257M |
| 3 |
Dollar General
DG
|
$257M |
| 4 |
Clorox
CLX
|
$242M |
| 5 |
Texas Roadhouse
TXRH
|
$224M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$363M |
| 2 |
Microsoft
MSFT
|
$328M |
| 3 |
Kenvue
KVUE
|
$286M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$285M |
| 5 |
Colgate-Palmolive
CL
|
$279M |
Sector Composition
| 1 | Healthcare | 20.81% |
| 2 | Consumer Discretionary | 17.77% |
| 3 | Technology | 17.49% |
| 4 | Consumer Staples | 12.02% |
| 5 | Industrials | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
NOV
NOV
$4.96B
| $63.2M | 0.25% |
3,115,733
+2,879,260
| +1,218% | +$58.4M |
|
127
Eli Lilly
LLY
$666B
| $62.4M | 0.24% |
107,081
+15,275
| +17% | +$8.9M |
|
128
SLM Corp
SLM
$6.62B
| $62.2M | 0.24% |
3,255,467
+912,806
| +39% | +$17.5M |
|
129
Novo Nordisk
NVO
$249B
| $61.8M | 0.24% |
+596,996
| New | +$61.8M |
|
130
Biohaven
BHVN
$1.7B
| $61.7M | 0.24% |
1,441,361
-528,391
| -27% | -$22.6M |
|
131
IDEAYA Biosciences
IDYA
$2.26B
| $60.5M | 0.24% |
1,700,135
+667,204
| +65% | +$23.7M |
|
132
US Bancorp
USB
$76.5B
| $59.8M | 0.23% |
1,382,272
+413,625
| +43% | +$17.9M |
|
133
Texas Capital Bancshares
TCBI
$3.99B
| $59.4M | 0.23% |
919,022
-154,327
| -14% | -$9.97M |
|
134
Post Holdings
POST
$5.86B
| $59.4M | 0.23% |
674,292
+652,265
| +2,961% | +$57.4M |
|
135
Interactive Brokers
IBKR
$28.6B
| $58.2M | 0.23% |
2,808,400
+1,401,028
| +100% | +$29M |
|
136
MoonLake Immunotherapeutics
MLTX
$3.79B
| $58.1M | 0.23% |
961,330
+855,508
| +808% | +$51.7M |
|
137
Pure Storage
PSTG
$25.7B
| $58M | 0.23% |
1,627,449
-1,740,696
| -52% | -$62.1M |
|
138
Pinnacle Financial Partners
PNFP
$7.71B
| $57.4M | 0.22% |
658,515
+217,963
| +49% | +$19M |
|
139
Globant
GLOB
$2.75B
| $57.2M | 0.22% |
+240,500
| New | +$57.2M |
|
140
Autoliv
ALV
$9.63B
| $55.2M | 0.22% |
500,803
+231,260
| +86% | +$25.5M |
|
141
Teva Pharmaceuticals
TEVA
$21.2B
| $54.9M | 0.21% |
5,258,195
+135,422
| +3% | +$1.41M |
|
142
Repligen
RGEN
$6.78B
| $54.8M | 0.21% |
+304,914
| New | +$54.8M |
|
143
Encompass Health
EHC
$12.5B
| $54.8M | 0.21% |
820,983
+188,175
| +30% | +$12.6M |
|
144
Elanco Animal Health
ELAN
$8.68B
| $54.6M | 0.21% |
3,664,122
-3,052,528
| -45% | -$45.5M |
|
145
Halliburton
HAL
$19.2B
| $52.3M | 0.2% |
+1,445,611
| New | +$52.3M |
|
146
Hershey
HSY
$37.6B
| $51.6M | 0.2% |
+276,847
| New | +$51.6M |
|
147
Enphase Energy
ENPH
$4.78B
| $51.4M | 0.2% |
+389,068
| New | +$51.4M |
|
148
Merck
MRK
$210B
| $51.3M | 0.2% |
+470,865
| New | +$51.3M |
|
149
Affirm
AFRM
$29.2B
| $50.3M | 0.2% |
1,024,443
-938,487
| -48% | -$46.1M |
|
150
Insmed
INSM
$30.1B
| $50M | 0.2% |
1,614,862
-193,626
| -11% | -$6M |
|